Neogen Chemicals Limited announced the outcome of its Board meeting held on February 11, 2026. The Board approved the Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. Key approvals also included granting in-principle approval to raise up to ₹150 crores via a preferential issue of equity shares to the Promoter Group. Additionally, the Nomination and Remuneration Committee approved the grant of 50,200 Stock Options under the NCL ESOP Scheme 2024.
Board Meeting Outcomes: February 11, 2026
The Board of Directors of Neogen Chemicals Limited, following a meeting that commenced at 2:30 p.m. and concluded at 7:30 p.m. on Wednesday, January 11, 2026 (Note: Date discrepancy in original text, using the official letter date of Feb 11, 2026 for context), approved several key items, primarily concerning financial reporting and capital restructuring.
Financial Results Approval (Q3 FY2026)
The Board approved the Un-audited (Standalone & Consolidated) Financial Results for the quarter and the nine months ended December 31, 2025. These results were accompanied by the Limited Review Report from the Statutory Auditors.
Standalone Financial Highlights (Q3 Ended Dec 31, 2025 vs. Q3 Ended Dec 31, 2024)
- Total Income (net): ₹219.86 Crore vs. ₹202.46 Crore.
- Profit for the period: ₹8.77 Crore vs. ₹14.41 Crore.
- Basic & Diluted EPS (Annualized basis not provided for Q3): ₹3.32 vs. ₹5.46.
Consolidated Financial Highlights (Q3 Ended Dec 31, 2025 vs. Q3 Ended Dec 31, 2024)
- Total Income (net): ₹222.11 Crore vs. ₹202.49 Crore.
- Profit for the period: ₹3.69 Crore vs. ₹10.01 Crore.
- Basic & Diluted EPS (Annualized basis not provided for Q3): ₹1.40 vs. ₹3.80.
Capital Raising via Preferential Issue
The Board granted In-principle approval to raise funds through the issuance of equity shares on a preferential basis. The aggregate amount proposed is up to ₹150 crores (inclusive of any premium). This approval is subject to necessary regulatory clearances and is based on the intent received from the Promoter Group.
Employee Stock Option Scheme (ESOP) Update
The Nomination and Remuneration Committee (NRC) met on February 11, 2026, and approved the following:
- The grant of 50,200 Stock Options (Tranche-II Grant) to 55 Eligible Employees under the “NCL ESOP Scheme 2024.”
- The vesting of 4,650 employee stock options granted previously in Tranche-I, effective from April 1, 2026.
Auditor’s Emphasis of Matter (Fire Incident)
The financial statements reflect an Emphasis of Matter regarding the fire incident at the Dahej SEZ Plant on March 05, 2025. The auditors confirm that the Standalone results presented a net loss of ₹13.56 crores related to the fire (Loss recognized: ₹348.16 Cr; Claim receivable: ₹334.60 Cr) under Exceptional Items for the year ended March 31, 2025.
For the Consolidated results, the corresponding net loss recognized under Exceptional Items for the year ended March 31, 2025, was ₹14.08 crores.
Compliance and Security Cover
The auditors provided a Certificate on maintenance of security cover and compliance with covenants related to the ₹200 Crore NCDs listed on the BSE as of December 31, 2025. The security coverage ratio (SCR) calculation, based on total assets against the debt, stood at 1.90 times (Standalone) and the Debt Equity Ratio was 1.55 times.
Source: BSE
